New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 25, 2014
14:51 EDTMDXGMiMedx addressed reimbursement fears on call, says Craig-Hallum
Craig-Hallum said MiMedx management outlined reimbursement scenarios for when the company no longer has pass-through status, calming the fears of some investors. Craig-Hallum also noted that the company raised the lower-end of its FY14 revenue guidance to $95M from $90M and that management said its meeting with the FDA about its micronized injectable products was both "productive and helpful." The firm reiterates its Buy rating and $10 price target on MiMedx.
News For MDXG From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
April 14, 2015
08:59 EDTMDXGMiMedx shares defended at Canaccord
Subscribe for More Information
April 13, 2015
19:18 EDTMDXGOn The Fly: After Hours Movers
Subscribe for More Information
16:17 EDTMDXGMiMedx sees FY15 revenue $175M-$190M, consensus $186.24M
16:17 EDTMDXGMiMedx reports preliminary Q1 revenue $40.8M, consensus $41.0
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use